Identification of genomic biomarkers for anthracycline-induced cardiotoxicity in human iPSC-derived cardiomyocytes: an in vitro repeated exposure toxicity approach for safety assessment
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of genomic biomarkers for anthracycline-induced cardiotoxicity in human iPSC-derived cardiomyocytes: an in vitro repeated exposure toxicity approach for safety assessment
Authors
Keywords
Cardiotoxicity, Human stem cells derived cardiomyocytes, Heart failure, Transcriptomics, Genomic biomarkers, In vitro test system, Safety assessment
Journal
ARCHIVES OF TOXICOLOGY
Volume 90, Issue 11, Pages 2763-2777
Publisher
Springer Nature
Online
2015-11-04
DOI
10.1007/s00204-015-1623-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mitochondrial oxidative metabolism and uncoupling proteins in the failing heart
- (2014) Alexander T. Akhmedov et al. HEART FAILURE REVIEWS
- Altered expression of genes for Kir ion channels in dilated cardiomyopathy
- (2013) Viktoria Szuts et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Disclosure of grounds of European withdrawn and refused applications: a step forward on regulatory transparency
- (2012) Giovanni Tafuri et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Cytochrome c oxidase dysfunction in oxidative stress
- (2012) Satish Srinivasan et al. FREE RADICAL BIOLOGY AND MEDICINE
- Opportunities for Use of Human iPS Cells in Predictive Toxicology
- (2011) B D Anson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Neuregulin1 as Novel Therapy for Heart Failure
- (2011) Xinhua Yan et al. CURRENT PHARMACEUTICAL DESIGN
- Anthracycline cardiotoxicity
- (2011) Pierantonio Menna et al. Expert Opinion On Drug Safety
- Growth Differentiation Factor-15: a New Biomarker in Cardiovascular Disease
- (2011) Tibor Kempf et al. HERZ
- Growth differentiation factor 15 in different stages of heart failure: potential screening implications
- (2010) Fangfang Wang et al. BIOMARKERS
- Uncoupling protein downregulation in doxorubicin-induced heart failure improves mitochondrial coupling but increases reactive oxygen species generation
- (2010) Heiko Bugger et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- REVIEW: Sodium Channel (Dys)Function and Cardiac Arrhythmias
- (2010) Carol Ann Remme et al. Cardiovascular Therapeutics
- GeneCards Version 3: the human gene integrator
- (2010) M. Safran et al. Database-The Journal of Biological Databases and Curation
- Doxorubicin Inactivates Myocardial Cytochrome c Oxidase in Rats: Cardioprotection by Mito-Q
- (2009) Karunakaran Chandran et al. BIOPHYSICAL JOURNAL
- Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction
- (2009) S. Q. Khan et al. EUROPEAN HEART JOURNAL
- Evaluation of the usefulness of biomarkers for cardiac and skeletal myotoxicity in rats
- (2009) Yutaka Tonomura et al. TOXICOLOGY
- In Vitro Electrophysiological Drug Testing Using Human Embryonic Stem Cell Derived Cardiomyocytes
- (2008) Oren Caspi et al. STEM CELLS AND DEVELOPMENT
- Cardiac troponin is the most effective translational safety biomarker for myocardial injury in cardiotoxicity
- (2007) Peter James O’Brien TOXICOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now